05 Nov, EOD - Indian

SENSEX 79476.63 (0.88)

Nifty 50 24213.3 (0.91)

Nifty Bank 52207.25 (1.94)

Nifty IT 40424.6 (0.01)

Nifty Midcap 100 56115.45 (0.59)

Nifty Next 50 69797.45 (0.55)

Nifty Pharma 22661.25 (0.10)

Nifty Smallcap 100 18503.45 (0.43)

05 Nov, EOD - Global

NIKKEI 225 38474.9 (1.11)

HANG SENG 21006.97 (2.14)

S&P 5824.25 (1.20)

Login/Signup
LOGIN HERE
Cancel

Sadhana Nitro Chem Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 506642 | NSE Symbol : SADHNANIQ | ISIN : INE888C01040 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
05-Aug-2024 08-Aug-2024 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of the board of directors of Sadhana Nitro Chem Limited (the Company') is scheduled to be held on Thursday August 08 2024 inter alia: 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results along with the Limited review report of the company for the quarter ended June 30 2024 2. Any other business that may arise out of the discussion during the meeting. Outcome of Board meeting held on August 08, 2024 (As Per BSE Announcement Dated on: 08/08/2024)
10-May-2024 17-May-2024 Final Dividend SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulation 2015 we wish to inform you that a meeting of thwe Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Friday May 17 2024 inter alia: 1. to consider the Audited Stanalone and Consolidated Financial Results and Statements for the quarter and Financial year ended March 31 2024. 2. To Consider the recommendation of Dividend for the financial year 2023-24. 3. Any other business that may arise out of the discussion during the meeting. Outcome of Board Meeting held on May 17, 2024 (As Per BSE Announcement Dated on: 17/05/2024)
23-Jan-2024 30-Jan-2024 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve Sadhana Nitrochem Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve Unaudited Standalone and Consolidate Financial Results along with Limited Review Report of the Company for the quarter ended December 31 2023 Pursuant to regulation 30 and 33 of SEBI (LODR) Regulations, 2015, the board of directors of the company, at its meeting held today, i.e. January 30, 2024 has considered, approved and taken on records the unaudited financial results (Standalone and Consolidate) along with Limited review report of the Company, for the quarter and nine month ended December 31, 2023. A copy of the said results along with the Limited review report issued by the Statutory Auditor of the company is attached herewith. Pursuant to regulation 30 and 33 of SEBI (LODR) Regulation, 2015, the Board of Directors of the Company, at its meeting held today i.e. Tuesday, January 30, 2024 has inter-alia: 1. Considered, approved and taken on record Unaudited financials results (Standalone and Consolidate) for the quarter and nine month ended December 31, 2023 2. Considered and approved the re-appointment of Shri. Asit D. Javeri as Executive Director 3. Considered and approved the re-appointment of Shri. Abhishek A. Javeri as Executive Director 4. Considered and approvwed the re-appointment of Smt. Seema A. Javeri as Executive Director (As Per BSE Announcement dated on 30.01.2024)
29-Nov-2023 02-Dec-2023 Right Issue SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2023 inter alia to consider and approve and evaluate a proposal for raising funds in one or more tranches through right issue of Equity Shares at such premium if any or such other methods or combinations as may be decided by the Board. Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended the Board of Directors at their meeting held today i.e., Saturday, December 2, 2023, has, inter alia approved the following: 1. Fundraising by way of an issuance of equity shares of face value of 1/- each of the Company to its eligible equity shareholders on the terms and conditions as mentioned in attached outcome 2. Increase in Authorised Share Capital of the company from Rs 30,00,00,000 (Rupees Thirty Crores Only) divided into 30,00,00,000 (Thirty Crores only) equity shares of Re.1/- each to Rs. 60,00,00,000 (Rupees Sixty Crore Only) divided into 60,00,00,000 (Sixty Crores only) equity shares of Re.1/- each and alter the Clause - V (Capital Clause) of Memorandum of Association relating to Share Capital of the Company. (As Per BSE Announcement Dated on 02.12.2023)
18-Oct-2023 26-Oct-2023 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report of the company for the quarter and half year ended September 30 2023. Pursuant to Regulation 33 of SEBI(LODR) Regulations, 2015, the Board of Directors of the Company at their meeting held today i.e. October 26, 2023 approved Unaudited Standalone and Consolidated Financial Results along with LRR for the quarter and half year ended September 30, 2023 (As Per BSE Announcement dated on 26.10.2023)
31-Jul-2023 07-Aug-2023 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report of the company for the quarter ended June 30 2023 We would like to inform that pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, i.e., August 07, 2023 at 10, Bruce Street, 1st Floor, 8/12, Homi Modi Street, Fort, Mumbai - 400001, inter alia transacted the following business: 1. Considered and approved and taken on record the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report of the Auditor of the Company, for the quarter ended June 30, 2023. A copy of the same is enclosed herewith as Annexure A. 2. Appointed M/s. MMJB & Associates LLP as the Secretarial Auditor of the Company for the Financial Year 2023-24 to conduct the Secretarial Audit of the Company. Details enclosed in Annexure-B. (As per BSE Announcement Dated on 07/08/2023)
16-May-2023 24-May-2023 Accounts SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve Dear Sir/Madam Pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Wednesday May 24 2023 to transact inter alia the following: 1. To consider the Audited Standalone and Consolidated Financial Results and Statements for the quarter and Financial Year ended March 31 2023. 2. To consider the Recommendation of Dividend for the Financial Year 2022-23. 3. To consider the proposal for declaration of Bonus Shares. 4. Any other business that may arise out of the discussion during the meeting. Kindly take the same on record. We hereby inform you that the Board of Directors of Sadhana Nitro Chem Limited at their meeting held today, i.e., Wednesday, May 24, 2023 , inter alia transacted the following business: Approved and taken on record the Audited Standalone and Consolidated Financial Results of the Company, for the quarter and financial year ended March 31, 2023, Considered and recommended a final dividend @ 15% i.e., Rs. 0.15 per equity share of face value of Rs.1/- each for the financial year 2022-23, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company. Considered and approved the proposal for issuance of bonus shares in proportion of 2 (Two) Bonus equity shares for every 9 (Nine) equity shares of Face Value of Rs. 1/- each held by the shareholders of the Company as on record date, subject to the approval of shareholders by postal ballot. Please refer to the attached PDF for other matters for your reference (As Per BSE Announcement Dated on 24.05.2023)
07-Feb-2023 14-Feb-2023 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report of the company for the quarter and nine months ended December 31 2022 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, i.e., February 14, 2023 at 10, Bruce Street, 1st Floor, 8/12, Homi Modi Street, Fort, Mumbai - 400001, inter alia have approved and taken on record the Unaudited Standalone and Consolidated Financial Results together with the Limited Review Report of the Auditor of the Company, for the quarter and nine months ended December 31, 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, i.e., February 14, 2023 at 10, Bruce Street, 1st Floor, 8/12, Homi Modi Street, Fort, Mumbai - 400001, inter alia have approved and taken on record the Unaudited Standalone and Consolidated Financial Results together with the Limited Review Report of the Auditor of the Company, for the quarter and nine months ended December 31, 2022. (As Per BSE Announcement Dated on 14.02.2023)
07-Nov-2022 14-Nov-2022 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Monday November 14 2022 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the quarter and half year ended September 30 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, ie, November 14, 2022 at 10, Bruce Street, 1st Floor, 8/12, Homi Modi Street, Fort, Mumbai - 400001, inter alia have approved and taken on record the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter and half year ended September 30, 2022. A copy of the same is enclosed herewith as Annexure A. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, ie, November 14, 2022 at 10, Bruce Street, 1st Floor, 8/12, Homi Modi Street, Fort, Mumbai - 400001, inter alia have approved and taken on record the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter and half year ended September 30, 2022. A copy of the same is enclosed herewith as Annexure A. (As Per BSE Announcement Dated on 14.11.2022) Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed herewith the copies of newspaper publication of Standalone and Consolidated Unaudited Financial Results of Sadhana Nitro Chem Limited ('the Company') for the quarter and half year ended September 30, 2022 approved at the meeting of Board of Directors of the Company held on Monday, November 14, 2022 in the following newspapers: 1. Financial Express dated November 15, 2022 2. Mumbai Lakshadeep dated November 16, 2022. Kindly take the same on record. (As Per BSE Announcement Dated on 16/11/2022)
05-Aug-2022 12-Aug-2022 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Friday August 12 2022 inter alia to consider and approve the following transactions: 1. Un-audited Standalone and Consolidated Financial Results along with Limited review Report of the company for the quarter ended June 30 2022. 2. Any other business that may arise out of the discussion of the Board. We further wish to inform you that the trading window for dealing in securities of the Company is already closed and the intimation of the same is given to BSE by the Company and shall remain closed till 48 hours after the declaration of Un-audited Financial Results along-with Limited Review Report thereon for the quarter ended June 30 2022 in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with Circular (Ref No. CIR/CFD/F AC/6212016 dated July 05, 2016, we hereby inform you that the Board of Directors of Sadhana Nitro Chem Limited ('the Company') at their meeting held on Friday, August 12, 2022 at 10, Bruce Street, 1st Floor, 8/12, Sir Homi Modi Street, Fort, Mumbai-400001 inter-alia transacted the following items of business: 1. Considered and approved Un-audited Standalone & Consolidated Financial Results along with Limited Review Report of the Company for the quarter ended June 30, 2022. (As per BSE Announcement Dated on 12/08/2022)
17-May-2022 24-May-2022 Accounts SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 it is hereby informed that the meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Tuesday May 24 2022 inter-alia to consider and approve the following transactions: 1. Audited Standalone and Consolidated Financial Results and Statements for the quarter and Financial Year ended March 31 2022. 2. Any other business that may arise out of the discussion of the Board. In continuation of our intimation dated May 17, 2022, we hereby wish to inform you that the meeting of the Board of Directors of Sadhana Nitro Chem Limited ('the Company') is scheduled to be held on Tuesday, May 24, 2022, in addition and inter alia to also consider and approve the following transaction: 1. Recommendation of Dividend, if any, for the Financial Year 2021-22. (as Per BSE Announcement Dated on 18-05-2022) Sadhana Nitro Chem Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2022, inter alia, has considered and recommended a dividend @ 15% i.e. Rs. 0.15 per equity share of face value of Rs.1/- each for the financial year 2021-22 on expanded capital after two bonus issue in the ratio of 1:2 in FY 2020-21 and in the ratio of 2:5 in the FY 2021-22 subject to approval of shareholders at the ensuing Annual General Meeting. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular (Ref No. CIR/CFD/F AC/6212016 dated July 05, 2016, we hereby inform you that the Board of Directors of Sadhana Nitro Chem limited ('the Company') at their meeting held on May 24, 2022, inter-alia transacted the following items of business: 1) Considered and approved Audited Standalone & Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 and took on record the Audit Report given by Statutory Auditor of the Company in this behalf. 2)Declaration from the CFO regarding unmodified opinion in the Audit Report issued by the Statutory Auditor of the Company on Standalone and Consolidated financial results. 'Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular (Ref No. CIR/CFD/F AC/6212016 dated July 05, 2016, we hereby inform you that the Board of Directors of Sadhana Nitro Chem limited ('the Company') at their meeting held on May 24, 2022, inter-alia transacted the following items of business: 1)Considered and approved Audited Standalone & Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 and took on record the Audit Report given by Statutory Auditor of the Company in this behalf. (As Per BSE Announcement Dated on 24.05.2022) Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed herewith the copy of newspaper publication of Standalone and Consolidated Audited Financial results of the company for the year ended March 31, 2022 approved at the meeting of the Board of Directors of the Company held on Tuesday, May 24, 2022 in the following newspaper: 1)Financial Express (As Per BSE Announcement Dated on 25.05.2022)
02-May-2022 02-May-2022 Others Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, the Company informs that: 1. Appointment of Shri. Rakesh R. Kothari as the Key Managerial Personal (KMP) Designated as Chief Financial Officer of the company with effect from May 02, 2022. 2.Resignation of Shri. Abhishek A. Javeri from the post of Chief Financial Officer of the Company pursuant to appointment of New Chief Financial Officer (CFO) with effect from May 02, 2022. However, he continues to be the Managing Director of the company. 3.The plant to manufacture Para Aminophenol (PAP) is ready. The production can commence once the Company receives permission to store Liquid ammonia from the Petroleum & Explosive Safety Organization (PESO)
07-Feb-2022 14-Feb-2022 Quarterly Results SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Monday February 14 2022 inter alia to consider and approve the following transactions: 1. Un-audited Standalone and Consolidated Financial Results along with Limited review Report of the company for the quarter and nine months ended December 31 2021. 2. Any other business that may arise out of the discussion of the Board. We further wish to inform you that the trading window for dealing in securities of the Company is already closed and the intimation of the same is given to BSE by the Company and shall remain closed till 48 hours after the declaration of Un-audited Financial Results along-with Limited Review Report thereon for the quarter and nine months ended December 31 2021 in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with Circular (Ref No. CIR/CFD/FAC/62/2016 dated July 05, 2016 we hereby inform you that the Board of Directors of Sadhana Nitro Chem limited ('the Company') at their meeting held on Monday, February 14, 2022 at 10, Bruce Street, 1st Floor, 8/12, Sir Homi Modi Street, Fort, Mumbai-400001 by means of Video Conferencing inter-alia transacted the following items of business: 1)Considered and approved Un-audited Standalone & Consolidated Financial Results along with Limited review Report of the Company for the quarter and nine months ended December 31, 2021. A copy of the same is enclosed herewith as Annexure-A 2)The Para Aminophenol (PAP) plant construction has been completed. Electrical Trials are starting this week. This will be followed by water run trials. On Conclusion of the water run trials, the plant will start commercial production. (As per BSE Announcement Dated on 14/02/2022) Pursuant to the above Regulations, we are enclosing herewith the copies of newspaper publication of Un-audited Financial results of the company for the quarter and nine months ended December 31, 2021 approved at the meeting of Board of Directors of the Company held on Monday, February 14, 2022 in the following newspaper: 1. Financial Express 2. Mumbai Lakshadeep (As Per BSE Announcement dated on 16.02.2022)
29-Jan-2022 02-Feb-2022 Others SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 inter alia to consider and approve Pursuant to Regulation 29(1)(d) and all other applicable regulations if any of the SEBI (LODR) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Wednesday February 02 2022 inter alia to consider the following transactions: 1)Proposal for raising of funds by way of issue of one or more of instruments comprising of equity shares convertible securities of any other description or warrants or debt securities through Private Placement/Preferential Issue/Qualified Institutions Placement or such other methods or combinations thereof as may be decided by the Board subject to such statutory/regulatory approvals as may be necessary including the approval of the Shareholders of the Company wherever required. 2)Conducting Postal Ballot process to seek approval of Shareholders inter-alia in respect of the aforesaid proposal(s) if the same are approved by the Board. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we hereby inform you that the Board of Directors of Sadhana Nitro Chem limited ('the Company') at their Meeting held today, February 02, 2022, inter-alia considered and approved issue of Share Warrants on preferential basis('Preferential Issue'')in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ('SEBI ICDR Regulations'')and the provisions of the Companies Act, 2013 and rules made there under. The preferential issue is subject to statutory approvals and approval of shareholders of the Company. (As Per BSE Announcement Dated on 02.02.2022)
18-Jan-2022 18-Jan-2022 Others Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Sadhana Nitro Chem limited ('the Company') at their meeting held on Tuesday, January 18, 2022 considered and approved listing of existing Equity Shares of the company on National Stock Exchange of India Limited (NSE).
1 2